CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 53:21 Webinar: Edgewise Therapeutics – A Novel Approach to Protect Muscle in Duchenne & Becker (October 2022) 2 years ago Research & Clinical Trial Webinars,Webinars 56:16 Connect With the Experts: Genitourinary Health (October 2022) 2 years ago Care Webinars,Webinars 58:15 Webinar: Psychosocial Considerations for Women in Duchenne (September 2022) 2 years ago Care Webinars,Webinars 1:00:00 Webinar: Medical Management of Women & Carriers (September 2022) 2 years ago Care Webinars,Webinars 1:06:21 Webinar: SRP-9001 Data Update from Studies 101, 102, and 103 (August 2022) 2 years ago Research & Clinical Trial Webinars,Webinars 46:05 Webinar: Casimir’s Duchenne Video Assessment (DVA) ARISE Study (August 2022) 2 years ago Research & Clinical Trial Webinars,Webinars 42:17 Webinar: Dyne Therapeutics Update on DYNE-251 (July 2022) 2 years ago Research & Clinical Trial Webinars,Webinars 1:02:42 Connect with the Experts: Pain Management (August 2022) 2 years ago Care Webinars,Webinars «1…45678…25»Page 6 of 25
by: Parent Project Muscular Dystrophy
